FHIR IG analytics| Package | hl7.eu.fhir.protect-child |
| Resource Type | Observation |
| Id | Observation-LiverHistologyEbvExample1.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Observation LiverHistologyEbvExample1
Profile: Patient Instrumental Investigation
identifier: ProtectChildId/IIV-1-0002
status: Final
code: Histopathology test
effective: 2023-09-15
performer: Organization La Paz University Hospital
value: Abnormal
| Code | Value[x] |
| Abnormality description | Portal and lobular mononuclear infiltrate, EBER-positive nuclei; no bile duct damage or endothelialitis — favours EBV hepatitis over rejection. |
{
"resourceType": "Observation",
"id": "LiverHistologyEbvExample1",
"meta": {
"profile": [
"https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/StructureDefinition/patient-instrumental-investigation"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"identifier": [
{
"system": "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id",
"value": "IIV-1-0002"
}
],
"status": "final",
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "252416005",
"display": "Histopathology test"
}
]
},
"subject": {
"reference": "Patient/ExamplePatientTransplant1"
},
"encounter": {
"reference": "Encounter/VisitExample1"
},
"effectiveDateTime": "2023-09-15",
"performer": [
{
"reference": "Organization/PCCenter1LaPaz"
}
],
"valueCodeableConcept": {
"coding": [
{
"system": "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/patient-instrumental-investigation-result-cs",
"code": "abnormal",
"display": "Abnormal"
}
]
},
"component": [
{
"code": {
"coding": [
{
"system": "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/patient-instrumental-investigation-component-cs",
"code": "abnormality",
"display": "Abnormality description"
}
]
},
"valueString": "Portal and lobular mononuclear infiltrate, EBER-positive nuclei; no bile duct damage or endothelialitis — favours EBV hepatitis over rejection."
}
]
}